Some have relabeled it as Pentadecapeptide Aringate or PDA (shifting the acetate to an arginate) and therefore are prescribing it for subcutaneous administration this way, while the confusion about its status has resulted in a vibrant oral capsule marketplace for BPC in what seems to generally be a gray region of legality.⚠ Critical: Neither pept